Ausgabe 3/2007
Inhalt (8 Artikel)
The mTOR pathway inhibitor RAD001 (everolimus) is highly efficacious in tamoxifen-sensitive and -resistant breast cancer xenografts
Diana Behrens, Anne E. Lykkesfeldt, Iduna Fichtner
Simple method to detect important epidermal growth factor receptor gene mutations with bronchoscopic specimens of lung cancer patients for gefitinib treatment
Kiwamu Akagi, Hiroshi Sakai, Junko Sudo, Yasuo Hommura, Futoshi Kurimoto, Hiroshi Komagata, Hirohiko Akiyama, Shuichi Yoneda
Role of the endothelins and endothelin receptors in cancer cell signaling and angiogenesis
Aïda Ghoul, Maria Serova, Christophe Le Tourneau, Nasredine Aïssat, Pascal Hammel, Eric Raymond, Sandrine Faivre
Reversible encephalopathy syndrome secondary to sunitinib for metastatic renal cell carcinoma patient
Jacques Medioni, Oana Cojocarasu, Eugeniu Banu, Alexia Cassar-Queudeville, Philippe Halimi, Stéphane Oudard